找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Tumor Suppressor Par-4; Role in Cancer and O Vivek M. Rangnekar Book 2021 Springer Nature Switzerland AG 2021 lung cancer.ovarian cancer.na

[復(fù)制鏈接]
查看: 6179|回復(fù): 35
樓主
發(fā)表于 2025-3-21 16:26:21 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Tumor Suppressor Par-4
副標(biāo)題Role in Cancer and O
編輯Vivek M. Rangnekar
視頻videohttp://file.papertrans.cn/931/930830/930830.mp4
概述Provides researchers and clinicians with new insights into potential drug discovery and development for various cancers and other human diseases.Describes the role of Par-4 in diverse diseases and the
圖書封面Titlebook: Tumor Suppressor Par-4; Role in Cancer and O Vivek M. Rangnekar Book 2021 Springer Nature Switzerland AG 2021 lung cancer.ovarian cancer.na
描述Par-4 is a naturally occurring tumor suppressor. Studies have indicated that overexpression of Par-4 selectively induces apoptosis in cancer cells while leaving normal, health, cells unaffected. Mechanisms contributing to this cancer-selective action of Par-4 have been associated with PKA activation of intracellular Par-4 in cancer cells or GRP78 expression primarily on the surface of cancer cells. On the other hand, endogenous Par-4 sensitizes cells to the action of a broad range of apoptotic inducers acting via the extrinsic and intrinsic pathways. A number of binding partners of Par-4 have been identified and shown to regulate Par-4 function in cancer and other diseases, such as Alzheimer’s and major depression. Recent studies have recognized a number of natural products, dietary supplements, synthetic molecules and FDA-approved drugs that induce the secretion of Par-4 protein to cause apoptosis in primary or metastatic tumors, one of which is in clinical trials. More than 50 different laboratories worldwide are involved in Par-4 based research of this unique protein that has progressed from the bench to clinical trials...This second, companion volume will provide a comprehensiv
出版日期Book 2021
關(guān)鍵詞lung cancer; ovarian cancer; nasopharyngeal carcinoma; GI tumors; endometrial cancer; prostate cancer; pan
版次1
doihttps://doi.org/10.1007/978-3-030-80558-6
isbn_ebook978-3-030-80558-6
copyrightSpringer Nature Switzerland AG 2021
The information of publication is updating

書目名稱Tumor Suppressor Par-4影響因子(影響力)




書目名稱Tumor Suppressor Par-4影響因子(影響力)學(xué)科排名




書目名稱Tumor Suppressor Par-4網(wǎng)絡(luò)公開度




書目名稱Tumor Suppressor Par-4網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Tumor Suppressor Par-4被引頻次




書目名稱Tumor Suppressor Par-4被引頻次學(xué)科排名




書目名稱Tumor Suppressor Par-4年度引用




書目名稱Tumor Suppressor Par-4年度引用學(xué)科排名




書目名稱Tumor Suppressor Par-4讀者反饋




書目名稱Tumor Suppressor Par-4讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:17:17 | 只看該作者
第130830主題貼--第2樓 (沙發(fā))
板凳
發(fā)表于 2025-3-22 04:21:00 | 只看該作者
板凳
地板
發(fā)表于 2025-3-22 06:55:18 | 只看該作者
第4樓
5#
發(fā)表于 2025-3-22 12:23:20 | 只看該作者
5樓
6#
發(fā)表于 2025-3-22 16:07:42 | 只看該作者
6樓
7#
發(fā)表于 2025-3-22 17:52:47 | 只看該作者
7樓
8#
發(fā)表于 2025-3-22 23:32:18 | 只看該作者
8樓
9#
發(fā)表于 2025-3-23 01:43:38 | 只看該作者
9樓
10#
發(fā)表于 2025-3-23 08:58:10 | 只看該作者
10樓
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 03:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
通城县| 若尔盖县| 新邵县| 贺兰县| 乐安县| 讷河市| 永泰县| 固始县| 寻乌县| 平定县| 股票| 浦县| 五大连池市| 丹巴县| 磐安县| 天镇县| 兴仁县| 沽源县| 六枝特区| 阜康市| 句容市| 柘城县| 台江县| 上思县| 武胜县| 尼玛县| 岢岚县| 聂荣县| 合川市| 泉州市| 花垣县| 广水市| 无锡市| 喜德县| 申扎县| 雷山县| 安福县| 当涂县| 金沙县| 绩溪县| 平陆县|